Cervical Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Cervical Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab in combination with lenvatinib for high-risk locally advanced cervical cancer is not yet recruiting…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications [Phase 1]
A Phase 1 clinical trial update describes evaluation of BBI-355 (CHK1 inhibitor) in combination with BBI-825 (RNR inhibitor) for tumors with…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer [NA]
A terminated clinical trial from MD Anderson studied conservative surgery for low-risk stage IA2/IB1 cervical cancer, with results posted on…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands [Phase 1]
Phase 1 clinical trial update of LGK974, a Wnt pathway inhibitor, in malignancies dependent on Wnt ligands; the study included several cance…
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery [Phase 3]
This Phase 3 trial evaluates radiation therapy with or without chemotherapy for Stage I-IIA cervical cancer in patients who had prior surger…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma [Phase 3]
A Phase 3 trial evaluating nimotuzumab in combination with chemotherapy for persistent or recurrent stage IVB cervical squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck [Phase 1]
Phase Ib trial of buparlisib (BKM120) with cisplatin and radiotherapy in high-risk locally advanced squamous cell carcinoma of the head and …
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers [Phase 3]
Phase 3 trial update evaluating adding Triapine to cisplatin-based chemoradiation for advanced cervical and vaginal cancers is in active not…
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer [Phase 1]
This Phase 1 trial evaluates atezolizumab given before and/or with chemoradiotherapy in node-positive stage IB2, II, IIIB, or IVA cervical c…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer [Phase 2]
Phase 2 trial evaluating ipilimumab in metastatic or recurrent HPV-related cervical cancer has completed; results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Study of Cemiplimab in Adults With Cervical Cancer [Phase 3]
Phase 3 study update of cemiplimab in adults with cervical cancer (recurrent/metastatic, platinum-refractory); results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix [Phase 3]
Phase 3 trial evaluating Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for cervical cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Phase 2 clinical trial update for ABI-007 in persistent or recurrent cervical cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix [Phase 3]
Phase 3 trial comparing four cisplatin-based combination chemotherapy regimens in advanced or recurrent cervical cancer; results posted afte…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Oral Rigosertib for Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating oral rigosertib for various squamous cell carcinomas has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Phase 2 trial evaluating veliparib with topotecan and G-CSF support in persistent or recurrent cervical cancer has completed with posted res…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer [Phase 2]
Phase 2 clinical trial evaluating complete nerve-sparing radical hysterectomy for cervical cancer has completed; the provided snippet does n…
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer [Phase 3]
A Phase 3 trial evaluating paclitaxel and cisplatin or topotecan with or without bevacizumab in stage IVB, recurrent, or persistent cervical…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer [Phase 2]
Phase 2 trial evaluating the combination of oxaliplatin and paclitaxel for locally recurrent or metastatic cervical cancer; results have bee…
-
CLINICAL_TRIALS trial_result · 2015-09-10Clinical Trial Update: Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial evaluating temsirolimus for recurrent, locally advanced, or metastatic cervical cancer, including various histologies…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix [Phase 2]
Phase 2 trial evaluating bevacizumab for persistent or recurrent cervical cancer completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer [Phase 2]
An NCI-sponsored Phase 2 study evaluated FDG and FMISO PET imaging to assess tumor hypoxia in cervical cancer; the trial has completed and r…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer [Phase 2]
Phase 2 clinical trial update on pelvic exenteration for recurrent cervical cancer, with completed status across cervical cancer subtypes.
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery [Phase 2]
A Phase 2 study evaluated sunitinib malate in patients with advanced cervical cancer (Stage IVB, recurrent, or unresectable), including aden…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer [Phase 1]
Phase 1 trial evaluating cetuximab with cisplatin and radiation therapy in cervical cancer (stages IB, IIB, III, and IVA) has completed. The…